Anti-heparin-platelet factor 4 antibodies are associated with arterial and venous thrombosis in patients with maintenance haemodialysis.
Tan
Ying
Y
Cao
Lei
L
Lv
Ji-Cheng
JC
Yan
Yu
Y
Zuo
Li
L
Wang
Mei
M
Yu
Lu
L
Yu
Feng
F
Zhao
Ming-Hui
MH
D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects* / Q000276:immunology*; D002681:China; D003430:Cross-Sectional Studies; D005260:Female; D006493:Heparin / Q000009:adverse effects* / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D008297:Male; D008875:Middle Aged; D010978:Platelet Factor 4 / Q000276:immunology*; D006435:Renal Dialysis / Q000009:adverse effects*; D013927:Thrombosis / Q000097:blood / Q000209:etiology* / Q000276:immunology; D020246:Venous Thrombosis / Q000097:blood / Q000209:etiology / Q000276:immunology
D000925:Anticoagulants; D007074:Immunoglobulin G; D010978:Platelet Factor 4; D006493:Heparin